Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

🤖 Plain-English Summary

IMPORTANCE: Updated estimates of non-small cell lung cancer (NSCLC) in the US are needed. A smaller proportion of patients aged 65 years or older with stage IV NSCLC were treated.

🔑 Key Findings

• OBJECTIVE: To calculate the most recent epidemiologic estimates of NSCLC in the US.
• DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional epidemiological analysis used the most recently released data from US cancer registries.
• The population-based US Cancer Statistics (USCS) database (2010-2017), comprised of the Surveillance, Epidemiology, and End Results (SEER) program and the National Program of Cancer Registries (NPCR) (collectively, SEER-NPCR) provided the NSCLC incidence estimate.

🔗 Related Resources